Drugs Fit Like Keys into Molecular Locks Flashcards
Ligand
A substance that binds to receptor molecules, such as a neurotransmitter or drug that binds postsynaptic receptors.
Figure 4.5
The Agonistic and Antagonistic Actions of Drugs
Agonist
A molecule, usually a drug, that binds a receptor molecule and initiates a response like that of another molecule, ususally a neurotransmitter.
Antagonist
A molecule, ususally a drug, that interferes with or prevents the action of a neurotransmitter.
Binding Affinity or Affinity
The propensity of molecules of a drug (or other ligand) to bind to receptors.
Efficacy or Intrinsic Activity
The extent to which a drug activates a response when it binds to a receptor.
Dose-Response Curve (DRC)
A formal graph of a drug’s effects (on the y-axis) versus the dose given (on the x-axis).
Figure 4.6
The Dose-Response Curve
Bioavailable
Referring to a substance, usually a drug, that is present in the body in a form that is able to interact with physiological mechanisms.
Biotransformation
The process in which enzymes convert a drug into a metabolite that is itself active, possibly in ways that are substantially different from the actions of the original substance.
Blood-Brain Barrier
The mechanisms that make the movement of substances from blood vessels into brain cells more difficult than exchanges in other body organs, thus affording the brain greater protection from exposure to some substances found in the blood.
Drug Tolerance
Also called simply tolereance. A condition in which, with repeated exposure to a drug, an individual becomes less responsive to a constant dose.
Metabolic Tolerance
The form of drug tolerance that arises when repeated exposure to the drug causes the metabolic machinery of the body to become more efficient at clearing the drug.
Functional Tolerance
The form of drug tolerance that arises when repeated exposure to the drug causes receptors to be up-regulated or down-regulated.
Down-Regulation
A compensatory decrease in receptor availability at the synapses of a neuron.